Bayer

Bayer
source
Name	Bayer
Type	Public
Traded as	FWB: BAYN, OTC: BAYRY
Industry	Pharmaceuticals, Chemicals, Biotechnology
Founded	1863
Founder	Friedrich Bayer, Johann Friedrich Weskott
Headquarters	Leverkusen, North Rhine-Westphalia, Germany
Key people	Werner Wenning, Stefan Oelrich
Products	Aspirin, Xarelto, Nexavar, Levitra
Revenue	€43.545 billion (2020)
Operating income	€4.919 billion (2020)
Net income	€4.173 billion (2020)
Total assets	€85.846 billion (2020)
Total equity	€37.442 billion (2020)
Num employees	103,824 (2020)
Subsidiaries	Monsanto, Bayer CropScience, Bayer HealthCare

Bayer. As a global leader in the pharmaceutical industry, chemical industry, and biotechnology sectors, Bayer has a rich history dating back to 1863, when it was founded by Friedrich Bayer and Johann Friedrich Weskott in Barmen, Rhineland. With its headquarters in Leverkusen, North Rhine-Westphalia, Germany, Bayer has become a household name, synonymous with innovative products such as Aspirin, Xarelto, and Nexavar. Through its subsidiaries, including Monsanto and Bayer CropScience, Bayer has expanded its reach into the agricultural industry, working closely with organizations like the Food and Agriculture Organization of the United Nations and the World Health Organization.

History of Bayer

Bayer's history is closely tied to the development of the pharmaceutical industry, with the company playing a significant role in the discovery and production of Aspirin, which was first synthesized by Felix Hoffmann in 1897. During World War I, Bayer produced Mustard gas and other chemical weapons for the German Empire, leading to a significant expansion of its production facilities. In the aftermath of the war, Bayer was forced to rebuild and restructure, eventually merging with other companies to form IG Farben in 1925, which later became a major supplier of Zyklon B to the Nazi regime during World War II. After the war, Bayer was rebuilt and re-established as an independent company, with a focus on pharmaceuticals and agrochemicals, working closely with organizations like the European Chemicals Agency and the United States Environmental Protection Agency.

Products and Services

Bayer's product portfolio includes a wide range of pharmaceuticals, such as Xarelto, Nexavar, and Levitra, which are used to treat various medical conditions, including thrombosis, cancer, and erectile dysfunction. The company also produces agrochemicals, such as glyphosate and imidacloprid, which are used in agriculture to control pests and weeds, and has partnered with companies like BASF and Dow Inc. to develop new products. Additionally, Bayer offers a range of consumer health products, including Aspirin and Aleve, which are used to treat pain and inflammation, and has collaborated with organizations like the World Health Organization and the Centers for Disease Control and Prevention to promote public health.

Research and Development

Bayer's research and development efforts are focused on developing innovative products and solutions for the pharmaceutical industry, agricultural industry, and biotechnology sectors. The company has established partnerships with leading research institutions, such as the Massachusetts Institute of Technology, Harvard University, and the University of California, Berkeley, to advance its research and development activities, and has also collaborated with companies like Pfizer and Merck & Co. to develop new products. Bayer's research and development pipeline includes a range of promising projects, such as the development of new cancer treatments and gene therapies, which are being conducted in collaboration with organizations like the National Cancer Institute and the European Medicines Agency.

Corporate Structure

Bayer's corporate structure is divided into three main divisions: Pharmaceuticals, Consumer Health, and Crop Science. The company is led by a board of management, which includes Werner Wenning and Stefan Oelrich, and is overseen by a supervisory board, which includes representatives from Deutsche Bank, Allianz, and other major shareholders, such as BlackRock and Vanguard Group. Bayer is listed on the Frankfurt Stock Exchange and is a component of the DAX stock market index, and has also been listed on the New York Stock Exchange and the London Stock Exchange.

Controversies and Criticisms

Bayer has faced several controversies and criticisms over the years, including concerns over the safety and environmental impact of its products, such as glyphosate and imidacloprid, which have been linked to bee deaths and water pollution. The company has also faced criticism for its role in the development and production of chemical weapons during World War I and World War II, and has been involved in several high-profile lawsuits, including a lawsuit over the Roundup herbicide, which was acquired from Monsanto in 2018, and has been the subject of investigations by regulatory agencies like the European Chemicals Agency and the United States Environmental Protection Agency.

Environmental Impact

Bayer's environmental impact is a significant concern, with the company's products and operations contributing to pollution, climate change, and biodiversity loss. The company has set targets to reduce its greenhouse gas emissions and water usage, and has implemented various initiatives to promote sustainable agriculture and conservation, such as the Bayer Foundation, which supports projects like the Green Belt and Road Initiative and the United Nations Sustainable Development Goals. However, Bayer's environmental impact remains a subject of controversy, with many critics arguing that the company needs to do more to address the environmental consequences of its products and operations, and has been the subject of criticism from organizations like the Sierra Club and the World Wildlife Fund. Category:Multinational companies